Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
CADUET
Generic name / active ingredient
amlodipine and atorvastatin
Dosage-form class
Amlodipine/atorvastatin fixed two-ingredient film-coated oral tablets: eight current-label combinations of 5 or 10 mg with 10, 20, 40 or 80 mg; each pair states the two ingredients in one tablet
Route
Oral
Record reviewed
2026-08-29

Copy from the pack in hand

Source-linked reading points

  • Check active ingredients on every pack. NORVASC is amlodipine alone and LIPITOR is atorvastatin alone; LOTREL, AZOR, EXFORGE, EXFORGE HCT and TRIBENZOR may also share amlodipine. Suspected duplication may be accidental or intentionally prescribed, and the site cannot decide from names alone. Do not add or stop a pack yourself.
  • Age 65 years or older, uncontrolled hypothyroidism, renal impairment, certain interacting medicines and higher strengths increase the labelled risk of myopathy and rhabdomyolysis. Promptly contact the care team for unexplained muscle pain, tenderness or weakness, especially with fever, malaise or dark urine; use local emergency services for severe or rapidly worsening symptoms, altered consciousness or markedly reduced urine.
  • The label identifies interaction boundaries involving grapefruit juice, some antivirals, clarithromycin, itraconazole, rifampin and digoxin. Do not use the site to stop a medicine, schedule separation or change a strength; have a pharmacist review the exact products, foods or drinks, supplements and complete medicine list.
  • Symptoms of serious liver injury, jaundice or markedly dark urine need timely medical assessment. Acute liver failure or decompensated cirrhosis is a labelled contraindication boundary; the site does not read laboratory values to decide continuation, interruption or adjustment.

Reviewed presentation examples — compare every field

  • Amlodipine 5 mg plus atorvastatin 10 mg per tablet; 30-tablet bottleNDC 58151-064-93
  • Amlodipine 5 mg plus atorvastatin 20 mg per tablet; 30-tablet bottleNDC 58151-065-93
  • Amlodipine 5 mg plus atorvastatin 40 mg per tablet; 30-tablet bottleNDC 58151-066-93
  • Amlodipine 5 mg plus atorvastatin 80 mg per tablet; 30-tablet bottleNDC 58151-067-93
  • Amlodipine 10 mg plus atorvastatin 10 mg per tablet; 30-tablet bottleNDC 58151-060-93
  • Amlodipine 10 mg plus atorvastatin 20 mg per tablet; 30-tablet bottleNDC 58151-061-93
  • Amlodipine 10 mg plus atorvastatin 40 mg per tablet; 30-tablet bottleNDC 58151-062-93
  • Amlodipine 10 mg plus atorvastatin 80 mg per tablet; 30-tablet bottleNDC 58151-063-93

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-29
Source record
5 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image